Medtronic Expects Revenue Growth In FY20 To Approximate 4.0% On Organic Basis
Novartis Reiterates Overall Strategy
Novartis Announces New Phase II Data For IND/GLY/MF
Merck To Acquire Privately Held Peloton Therapeutics
Dr. Reddy's Laboratories Q4 EPS $0.38 Vs $0.26 Last Year
Hikma Pharma Remains Confident In The Outlook For The Group